Sera Prognostics
IPOPublic · Salt Lake City, United States · Founded 2011 · $19.3M raised
- Headquarters
- Salt Lake City, Utah
- Employees
- 51–200
- Founded
- 2011
- Business Model
- B2B
- Website
- sera.com
- Total Funding
- $19.3M
- Last Round
- $19.3M Series AFeb 2011
- Rounds
- 1
- Type
- Public
About
Precision biomarker-based diagnostics company improving pregnancy outcomes through the PreTRM test for premature birth risk.
Summary
Sera Prognostics is a Biotech company based in Salt Lake City, United States, founded in 2011. It has raised $19.3M in total across 1 round, most recently a $19.3M Series A round in Feb 2011.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2011
Similar Companies
Minneapolis-based clinical stage biotechnology company focused on the development of molecularly ...
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.